Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationBone MarrowTransplantation ConditioningBone Marrow CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsCombined Modality TherapyMelphalanTreatment OutcomeCyclophosphamideGraft vs Host DiseaseHematopoietic Stem Cell MobilizationEtoposideHematopoietic Stem CellsGraft SurvivalRemission InductionAntigens, CD34Hematologic NeoplasmsBone and BonesSalvage TherapyDisease-Free SurvivalRecurrenceMyeloablative AgonistsBone Marrow PurgingWhole-Body IrradiationLymphoma, Non-HodgkinHodgkin DiseaseGranulocyte Colony-Stimulating FactorCytarabineSurvival RateLiver TransplantationBusulfanCarmustineSurvival AnalysisTransplantation ChimeraMesenchymal Stem Cell TransplantationRetrospective StudiesThiotepaVincristineTissue DonorsTime FactorsPrognosisCord Blood Stem Cell TransplantationFollow-Up StudiesCell DifferentiationCell TransplantationAmyloidosisLymphoma, Mantle-CellLeukemia, Myeloid, AcuteDoxorubicinHematopoiesisKidney TransplantationDexamethasoneEmbryonic Stem CellsBone Marrow DiseasesBoronic AcidsHistocompatibility TestingAntineoplastic Agents, AlkylatingLeukemiaPyrazinesAntineoplastic AgentsAdult Stem CellsAntibodies, Monoclonal, Murine-DerivedMyelodysplastic SyndromesLymphoma, FollicularLymphomaLymphoma, T-Cell, PeripheralImmunosuppressive AgentsLeukapheresisHistocompatibilityNeoplasm, ResidualCells, CulturedMesenchymal Stromal CellsThalidomideAutograftsBone Marrow ExaminationPrednisoneBone RemodelingIfosfamideFlow CytometryMice, Inbred C57BLPodophyllotoxinInduction ChemotherapyT-LymphocytesGraft vs Leukemia EffectBone Marrow NeoplasmsLeukemia, MyeloidTransplantation ImmunologyAntibodies, MonoclonalPrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationStem Cell NicheAnemia, AplasticPluripotent Stem Cells